Durvalumab vs Rabeprazole

Durvalumab vs Rabeprazole: Overview

This comparison examines the pharmacological differences between Durvalumab and Rabeprazole.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Rabeprazole: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Rabeprazole — 1-2 hours.

Chemical Properties

Molecular Formula: Rabeprazole — C18H21N3O3S.

Molecular Weight: Rabeprazole — 359.4440 g/mol.

Type: Durvalumab — Antibody; Rabeprazole — Small molecule.